Skip to main content

Arthur J. Gallagher & Co.

For the period ended Dec 31, 2023. Filed Feb 9, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 9, 2024

AJG$280.60-0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Schedule II - Valuation and Qualifying Accounts

Schedule II

Valuation and Qualifying Accounts

Balance atBeginningof Year · AmountsRecorded inEarnings · Adjustments · Balance atEndof Year
(In millions)
Allowance for doubtful accounts$11.1$26.0$(14.1)(1)$23.0
Allowance for estimated policy cancellations9.3(0.5)1.1(2)9.9
Valuation allowance for deferred tax assets135.260.6—195.8
Accumulated amortization of expiration
lists, non-compete agreements and trade names3,300.0531.342.2(3)3,873.5
Allowance for doubtful accounts$8.3$6.8$(4.0)(1)$11.1
Allowance for estimated policy cancellations10.02.4(3.1)(2)9.3
Valuation allowance for deferred tax assets154.9(19.7)—135.2
Accumulated amortization of expiration
lists, non-compete agreements and trade names2,924.0454.9(78.9)(3)3,300.0
Allowance for doubtful accounts$10.1$7.0$(8.8)(1)$8.3
Allowance for estimated policy cancellations9.9(1.3)1.4(2)10.0
Valuation allowance for deferred tax assets94.960.0—154.9
Accumulated amortization of expiration
lists, non-compete agreements and trade names2,537.0415.1(28.1)(3)2,924.0

(1)

Net activity of bad debt write offs and recoveries and acquired businesses.

(2)

Additions to allowance related to acquired businesses.

(3)

Elimination of fully amortized expiration lists, non-compete agreements and trade names, intangible asset/amortization reclassifications and disposal of acquired businesses.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.